Biosenta Inc. (ZRO.CN)
CAD 0.26
(-3.7%)
CAD 0.26
(-3.7%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -550.78 Thousand | -504.43 Thousand | -672.28 Thousand | -319.72 Thousand | -326.73 Thousand | -225.06 Thousand |
| Net Income | -6.29 Million | -1.45 Million | -2.04 Million | -761.9 Thousand | -530.08 Thousand | -1.18 Million |
| Depreciation & Amortization | - | - | - | - | - | 580.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 168.62 Thousand | 112.35 Thousand | 892.12 Thousand | - | - | - |
| Change in working capital | 790.46 Thousand | 810.69 Thousand | 381.45 Thousand | 421.02 Thousand | 195.27 Thousand | 47.08 Thousand |
| Other non-cash items | 4.78 Million | 30.77 Thousand | 197 Thousand | 21.15 Thousand | 8073.00 | 916.91 Thousand |
| Investing Cash Flow | -15.55 Thousand | - | - | - | - | - |
| Investments in PPE | -15.55 Thousand | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 544.96 Thousand | 419.81 Thousand | 739.86 Thousand | 354.38 Thousand | 325 Thousand | 234.78 Thousand |
| Debt repayment | -278.44 Thousand | -57.66 Thousand | -64.98 Thousand | -71.88 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 327.9 Thousand | - | - | - |
| Other Financing Activities | 823.41 Thousand | 477.47 Thousand | 476.93 Thousand | 426.27 Thousand | 325 Thousand | 234.78 Thousand |
| Accounts receivables | -14.56 Thousand | -142.01 Thousand | 1639.00 | -1639.00 | -3336.00 | -6565.00 |
| Accounts payables | 784.55 Thousand | 924.42 Thousand | 468.7 Thousand | 475.64 Thousand | 198.61 Thousand | 51.02 Thousand |
| Inventory | 2091.00 | 1150.00 | -45.92 Thousand | -31.18 Thousand | 3336.00 | 379.00 |
| Other working capital | 18.38 Thousand | 27.13 Thousand | -42.97 Thousand | -21.8 Thousand | -3336.00 | 46.7 Thousand |
| Cash at beginning of period | 27.26 Thousand | 111.88 Thousand | 44.3 Thousand | 9647.00 | 11.37 Thousand | 1657.00 |
| Cash at end of period | 5883.00 | 27.26 Thousand | 111.88 Thousand | 44.3 Thousand | 9647.00 | 11.37 Thousand |
| Capital Expenditure | -15.55 Thousand | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -21.38 Thousand | -84.61 Thousand | 67.57 Thousand | 34.66 Thousand | -1730.00 | 9720.00 |
| Free Cash Flow | -566.34 Thousand | -504.43 Thousand | -672.28 Thousand | -319.72 Thousand | -326.73 Thousand | -225.06 Thousand |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -547.29 Thousand | -495.06 Thousand | -471.13 Thousand | -6.29 Million | -5.22 Million | -494.45 Thousand |
| Depreciation & Amortization | 700.00 | 1556.00 | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 51.45 Thousand | 6000.00 | - | 168.62 Thousand | - | 143.25 Thousand |
| Change in working capital | 163.87 Thousand | 8827.00 | -4009.00 | 790.46 Thousand | 312.38 Thousand | 190.13 Thousand |
| Other non-cash items | 27.98 Thousand | 302.63 Thousand | 127.37 Thousand | 4.78 Million | 4.78 Million | -3017.00 |
| Investing Cash Flow | - | - | - | -15.55 Thousand | -15.55 Thousand | - |
| Investments in PPE | 5.00 | - | - | -15.55 Thousand | -15.55 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 187.89 Thousand | 51.58 Thousand | 486.49 Thousand | 544.96 Thousand | 117.55 Thousand | 184.59 Thousand |
| Debt repayment | -411.92 Thousand | -51.41 Thousand | -516.00 | -278.44 Thousand | -124.65 Thousand | -113.79 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 600 Thousand | - | 485.98 Thousand | - | - | - |
| Other Financing Activities | -172.00 | 172.00 | 1032.00 | 823.41 Thousand | 242.2 Thousand | 298.38 Thousand |
| Accounts receivables | -169.5 Thousand | -52.61 Thousand | -16.39 Thousand | -14.56 Thousand | 2865.00 | -106.00 |
| Accounts payables | 328.59 Thousand | 56.29 Thousand | 7669.00 | 784.55 Thousand | 306.84 Thousand | 106.00 |
| Inventory | 186.00 | 546.00 | 120.00 | 2091.00 | -1920.00 | 3703.00 |
| Other working capital | 4596.00 | 4596.00 | 4596.00 | 18.38 Thousand | 4596.00 | 186.43 Thousand |
| Cash at beginning of period | 15.26 Thousand | 144.61 Thousand | 5883.00 | 27.26 Thousand | 28.3 Thousand | 7810.00 |
| Cash at end of period | 6302.00 | 15.26 Thousand | 144.61 Thousand | 5883.00 | 5883.00 | 28.3 Thousand |
| Capital Expenditure | 5.00 | - | - | -15.55 Thousand | -15.55 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -8966.00 | -129.34 Thousand | 138.72 Thousand | -21.38 Thousand | -22.42 Thousand | 20.49 Thousand |
| Free Cash Flow | -196.86 Thousand | -180.92 Thousand | -347.76 Thousand | -566.34 Thousand | -139.97 Thousand | -164.09 Thousand |
AEL
CONTILI
BOTI
AXIC-A
ANGVF
CTARAF